Tavaborole (Kerydin)

Rx Prescription only

Well-established Evidence

Ingredient Type

Evidence by concern

Nail Fungus First-line active How we graded these ↓

Tavaborole (Kerydin) is prescription-only

We review what you can buy over the counter, so nothing carrying it appears here. This page is the reference — what it does, what the evidence supports, and what to raise with a prescriber.

The full tavaborole (kerydin) guide

Boron rarely appears in medicine, which makes tavaborole an oddity twice over: it is the first oxaborole drug approved anywhere, and the boron atom is not decoration but the working end of the molecule.

Approved in July 2014 for toenail fungus, it was built around a single physical constraint — get small enough to cross the nail plate — and the boron chemistry is what let the designers stay small while still hitting a target no other antifungal touches.

Where the evidence stands, by concern

Evidence for an ingredient is not one grade — it differs concern by concern. Each row below was researched separately against regulatory approvals, clinical guidelines, and trials our team opened and verified; the band and dots rank how central tavaborole (kerydin) is to treating that concern, from first-line therapy down to supportive care, at treatment-level doses and vehicles. A product's own grade weighs its actual formula.

Nail Fungus First-line active Regulator-approved Prescription only

Evidence certainty: Well-established · TAVABOROLE- tavaborole topical solution, 5% solution

How it's regulated in the US

FDA does not classify ingredients — it classifies products, by what they are sold to do. The same molecule can be a drug active in one product and a cosmetic ingredient in the next, and only the claim on the label decides which. What follows is a statement about that legal standing, not about whether it works — the evidence question is answered separately above.

Approved drug Tavaborole is prescription-only, approved for toenail onychomycosis on the strength of its unusually small molecule penetrating the nail plate.

nail fungus FDA-approved 5 percent topical solution

Approved by FDA as a generic of an approved drug

Permitted label wording “For the treatment of onychomycosis of the toenails”

TAVABOROLE- tavaborole topical solution, 5% solution

Two randomized, double-blind, vehicle-controlled phase 3 studies published in the Journal of the American Academy of Dermatology in 2015 tested 5% solution applied daily for 48 weeks. Complete cure reached 6.5% and 9.1% against 0.5% and 1.5% on vehicle — statistically convincing, clinically modest, and a fair snapshot of what topical onychomycosis therapy can currently deliver. Cochrane's 2020 review of topical and device-based treatments for toenail fungal infections included the drug and placed the whole topical class well below oral terbinafine. Its FDA approval under NDA 204427 covers infection by Trichophyton rubrum and Trichophyton mentagrophytes specifically; efficacy against other organisms was not established in the pivotal programme.

How it works

Every cell needs aminoacyl-tRNA synthetases — the enzymes that load each amino acid onto its matching transfer RNA before protein synthesis can proceed. Fungal leucyl-tRNA synthetase carries a separate proofreading pocket, an editing site whose job is to correct mistakes. Tavaborole's boron atom forms a bond inside that editing site and traps the enzyme with tRNA still attached. The enzyme cannot release its cargo, leucyl-tRNA stops being made, protein synthesis halts, and the fungus dies. Nothing else in the topical antifungal cabinet works this way, so there is no cross-resistance with azoles or with ciclopirox. Boron is doing structural work here rather than pharmacological work of its own. Its ability to shift between three- and four-coordinate forms is what lets a very small molecule bind an enzyme pocket that would normally require something much bulkier — and size is the entire clinical problem in nail disease. The nail plate is a dense keratin barrier that stops most drugs cold; tavaborole's low molecular weight and slight water solubility let it move through the plate to the nail bed below, which ex vivo human nail studies and pharmacokinetic work both confirm. The vehicle is a thin alcohol-based dropper solution rather than a lacquer. It spreads and evaporates, leaving no film to remove, which is why the regimen has no weekly debridement step — and why the bottle is flammable while wet.

Key benefits

A protein-synthesis target no other topical antifungal shares
No cross-resistance with azole or hydroxypyridone nail treatments
Small molecule crosses the nail plate to reach the nail bed
Daily dropper application with no filing or lacquer removal
Systemic exposure low enough to avoid oral antifungal blood monitoring
Approved from age six, with paediatric pharmacokinetic data available

Concentration & usage

One approved presentation: 5% topical solution, prescription-only, applied once daily to the whole nail surface and under the free edge with the dropper, for 48 weeks. There is no over-the-counter version, and boron-containing cosmetic nail products are not this molecule. The label is candid about a question people always ask — the effect of nail polish and other cosmetic nail products on efficacy has not been evaluated, so the honest answer is that nobody knows, and the trials were run on bare nails. Discard the bottle within three months of first inserting the dropper. Assess the result at week 52, not before; the nail's growth rate, not the drug, sets that clock.

Who it's for & who should be cautious

Who it's for

It suits limited mild-to-moderate toenail onychomycosis, particularly confirmed dermatophyte infection, in someone who cannot or would rather not take oral terbinafine — because of liver disease, drug interactions, or simply a preference against systemic therapy for a cosmetic-to-moderate problem. The distinct mechanism makes it a reasonable option after an azole-based topical has failed, since the resistance and penetration reasons for that failure do not carry over.

Who should be cautious

Anyone expecting a clear nail should look hard at the numbers first: fewer than one in ten people reached complete cure in the pivotal trials, and that is after a year of daily application. Extensive involvement, several affected nails, thick dystrophic nails or disease reaching the matrix all argue for oral therapy instead. Confirm the diagnosis before committing a year — nail psoriasis, repetitive trauma and lichen planus all mimic fungal change and none respond. Application-site exfoliation, ingrown toenails and local redness each occurred in one to three percent of trial users. Human pregnancy data are absent and animal studies showed embryofetal toxicity at high oral doses. The solution is flammable until dry.

Pairs with & conflicts

Pairs well with: Urea (Carbamide), Efinaconazole (Jublia), Ciclopirox (Ciclopirox Olamine), Tea Tree Oil (Melaleuca alternifolia)

Myths & facts

Myth: Boron is the active ingredient, so boric acid or a boron supplement would do something similar.

Reality: The boron atom matters because of where it sits in a specific molecular scaffold — it forms a covalent bond inside the editing site of fungal leucyl-tRNA synthetase. Free boron compounds have no such geometry and no comparable antifungal activity in nails. Borax foot soaks are a folk remedy with no trial evidence, not a cheap version of this drug.

Myth: A single-digit cure rate means the drug failed and should not have been approved.

Reality: Complete cure requires a totally clear nail plus negative microscopy and culture in tissue that regrows over twelve to eighteen months, and the vehicle arms cured under 2%. The drug tripled to sixfold that rate on a demanding endpoint. The reasonable criticism is that all topical onychomycosis therapy has a low ceiling, not that this molecule underperforms its class.

Myth: It works like the azole nail treatments, so there's no point switching between them.

Reality: Azoles block ergosterol synthesis in the cell membrane; tavaborole traps a protein-synthesis enzyme via its boron atom. Those are unrelated targets with no shared resistance pathway, which is exactly why a switch after azole failure is mechanistically sensible — even if, in practice, penetration and adherence explain more failures than resistance does.

Frequently asked questions

How long do I have to use tavaborole before I see a clear toenail?

The approved course is 48 weeks of daily application with the outcome judged at week 52, and that schedule reflects how slowly toenails grow rather than how quickly the fungus dies. Healthy nail appears at the base long before the damaged portion reaches the tip. Abandoning it at month three, when nothing looks different, is the most common way the treatment fails.

Can I wear nail polish while using tavaborole?

The label states the effect of polish and other cosmetic nail products on efficacy has not been evaluated — so the truthful answer is unknown, and the trials were conducted on bare nails. Given the solution has to spread across and under the nail to work, layering it over lacquer day after day works against the design.

How does tavaborole compare with efinaconazole for nail fungus?

Efinaconazole reported higher complete cure rates in its own pivotal trials, though the two have not been compared head-to-head, so cross-trial comparison should be read with caution. Both are daily 48-week topicals with no debridement requirement. Cost, coverage and prior treatment history usually settle the choice.

Do I still need to see someone about my nail if I use this?

Confirming the diagnosis first is worth more than any product choice — a meaningful share of thickened, discoloured nails are not fungal at all, and psoriasis or old trauma will not respond to a year of antifungal solution. A clipping sent for microscopy and culture is a small step that prevents a long, expensive, pointless course.

Why does the bottle warn about flame?

The vehicle is largely alcohol, which is what keeps the solution thin enough to wick under the nail edge. That makes it flammable while wet, so keep it away from lit cigarettes, candles and heat sources during application. Once dried, the warning no longer applies.

Sources